Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Docetaxel in Advanced STS or Refractory GIST
NCT00359333Phase 2Completed
- Sponsor
- National Health Research Institutes
- Start
- Dec 2006
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, docetaxel in soft tissue sarcoma (STS), gastrointestinal stromal tumor (GIST), sponsored by National Health Research Institutes. Started Dec 2006; status: completed.
02
Drugs
gemcitabinedocetaxel
03
Conditions
soft tissue sarcoma (STS)gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00359333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00359333.